Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04971889
Other study ID # 21-02-1069
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2021
Est. completion date June 2023

Study information

Verified date August 2022
Source Meharry Medical College
Contact Stephania Miller-Hughes, PhD
Phone 16153275666
Email smiller@mmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.


Recruitment information / eligibility

Status Recruiting
Enrollment 291
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender Female
Age group 21 Years and older
Eligibility Inclusion Criteria: - African American - Female - Clinical diagnosis of type 2 diabetes for at least 6 months - At risk for development and/or progression of diabetes complications (HbA1c = 7.0% AND either systolic blood pressure =130, LDL cholesterol = 100, or BMI = 30). Exclusion Criteria: --Observed or diagnosed psychotic disorders

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Diabetes MNT
Group-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake
Motivational Interviewing
Group-based support for dietary self-care motivation using culturally-adapted motivational interviewing exercise

Locations

Country Name City State
United States Matthew Walker Comprehensive Health Center Nashville Tennessee
United States Meharry Medical College Nashville Tennessee

Sponsors (4)

Lead Sponsor Collaborator
Meharry Medical College Matthew Walker Comprehensive Health Center, Patient-Centered Outcomes Research Institute, Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Carbohydrate Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management. Baseline
Other Change from baseline Carbohydrate Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management. 3 months
Other Change from baseline Carbohydrate Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management. 6 months
Other Change from baseline Carbohydrate Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management. 12 months
Other Fat Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management. Baseline
Other Change from baseline Fat Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management. 3 months
Other Change from baseline Fat Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management. 6 months
Other Change from baseline Fat Management Attitude Scale Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management. 12 months
Other Diabetes Empowerment Scale Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care. Baseline
Other Change from baseline Diabetes Empowerment Scale Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care. 3 months
Other Change from baseline Diabetes Empowerment Scale Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care. 6 months
Other Change from baseline Diabetes Empowerment Scale Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care. 12 months
Other Problem Areas in Diabetes Scale Questionnaire Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills. Baseline
Other Change from baseline Problem Areas in Diabetes Scale Questionnaire Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills. 3 months
Other Change from baseline Problem Areas in Diabetes Scale Questionnaire Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills. 6 months
Other Change from baseline Problem Areas in Diabetes Scale Questionnaire Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills. 12 months
Other Situational Obstacles to Dietary Adherence Questionnaire Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options. Baseline
Other Change from baseline Situational Obstacles to Dietary Adherence Questionnaire Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options. 3 months
Other Change from baseline Situational Obstacles to Dietary Adherence Questionnaire Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options. 6 months
Other Change from baseline Situational Obstacles to Dietary Adherence Questionnaire Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options. 12 months
Primary HbA1c Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples. Baseline
Primary Change from Baseline HbA1c Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples. 3 months
Primary Change from Baseline HbA1c Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples. 6 months
Primary Change from Baseline HbA1c Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples. 12 months
Secondary Body Mass Index Calculated measure of body max index from height/weight measures Baseline
Secondary Change from Baseline Body Mass Index Calculated measure of body max index from height/weight measures 3 months
Secondary Change from Baseline Body Mass Index Calculated measure of body max index from height/weight measures 6 months
Secondary Change from Baseline Body Mass Index Calculated measure of body max index from height/weight measures 12 months
Secondary LDL Cholesterol Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values. Baseline
Secondary Change from baseline LDL Cholesterol Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values. 3 months
Secondary Change from baseline LDL Cholesterol Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values. 6 months
Secondary Change from baseline LDL Cholesterol Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values. 12 months
Secondary Systolic Blood Pressure A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated. Baseline
Secondary Change from baseline Systolic Blood Pressure A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated. 3 months
Secondary Change from baseline Systolic Blood Pressure A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated. 6 months
Secondary Change from baseline Systolic Blood Pressure A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated. 12 months
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A